×

Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

Shop picked for Viagra rival

Published on .

The next impotence product is likely to come from Schering-Plough Corp., Liberty Corner, N.J., which awarded its Vasomax direct-to-consumer prescription brand to Robert A. Becker Euro RSCG, New York. Though Vasomax awaits U.S. Food & Drug Administration approval, Schering is expected to spend competitively against Pfizer's Viagra, which is supported by a $35 million campaign from Cline Davis Mann, New York, that broke last month.

Copyright July 1998, Crain Communications Inc.

Most Popular
In this article: